Skip to content
SlushFund

Companies · USAspending parent record

ANEON BRILLIENT, LLC

No confirmed stock ticker. 1 recipient record grouped under this USAspending parent (UEI MS8HMAY331Q5).

Non-competed awards
$20.8M

obligated to date on 10 non-competed awards of $1M+ signed FY2024–26

USAspendingas of Oct 3

Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.

Awards in our records
10

10 non-competed ($1M+) · 0 other ($10M+)

USAspendingas of Oct 3
Largest award
$3.3M

obligated to date: 75F40124C00111, Department of Health and Human Services, signed FY2024

USAspendingas of Oct 3
Member trades
No ticker

No confirmed stock ticker, so no member trades are matched to this company.

House Clerk + Senate eFDas of Oct 4
Source: USAspending.gov · SEC EDGAR company tickers · House Clerk PTRs · Senate eFDCoverage: Contract awards FY2024–FY2026 · Ticker links FY2024–26 recipients · House 2021–2026 · Senate 2024–2026Updated: Methodology →

Federal contract awards in our records

Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.

What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.

Awards by fiscal year signed (obligated to date, not spending in the year)
Signed inNon-competed awardsObligated to dateOther awards $10M+Obligated to date
FY20247$14.1MNone in this set—
FY20252$4.9MNone in this set—
FY2026incomplete1$1.9MNone in this set—

FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.

FY2024 awards to ANEON BRILLIENT, LLC, largest first (obligated to date)
Source
75F40124C00111DIRECT 8(A) AWARD OF A 12-MONTH BASE, LABOR HOUR TYPE CONTRACT TO ANEON BRILLIENT FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) FOR PROFESSIONAL SERVICES SUPPORT.Department of Health and Human ServicesAug 21, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$3,266,336USAspending
75F40124C00085DIRECT 8(A) AWARD OF A 3-YEAR, LABOR-HOUR (LH) TYPE CONTRACT FOR COMMUNICATION, ADMINISTRATIVE & INFORMATION DISCLOSURE SUPPORT SERVICES FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), OFFICE OFDepartment of Health and Human ServicesAug 26, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$2,366,901USAspending
75F40124C00090DIRECT 8(A) AWARD OF A 12-MONTH BASE AND 9-MONTH OPTION, LABOR HOUR TYPE CONTRACT TO ANEON BRILLIENT FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) FOR PROFESSIONAL SERVICES.Department of Health and Human ServicesAug 2, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$2,214,286USAspending
75F40124C00068DIRECT 8(A) AWARD, STAND-ALONE, LABOR-HOUR (LH) TYPE CONTRACT FOR FOOD AND DRUG ADMINISTRATION ONCOLOGY CENTER FOR EXCELLENCE ONCOLOGY CENTER OF EXCELLENCE PROFESSIONAL SERVICES.Department of Health and Human ServicesJun 24, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,866,747USAspending
75F40124C00076DIRECT 8(A) AWARD OF A 3-YEAR, LABOR-HOUR (LH) TYPE CONTRACT FOR PROGRAM SUPPORT SERVICES FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), OFFICE OF POLICY, LEGISLATION AND INTERNATIONAL AFFAIRS (OPLIA)Department of Health and Human ServicesAug 27, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,619,126USAspending
75F40124C00115DIRECT 8(A) AWARD OF 4-YEAR, LABOR HOUR TYPE CONTRACT TO ANEON BRILLIENT TO PROVIDE MEDICAL AND SCIENTIFIC WRITING & EDITING FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)Department of Health and Human ServicesAug 21, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$1,576,247USAspending
75F40124C00109THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HEREBY INTENDS TO PROCURE THE FREEDOM OF INFORMATION ACT (FOIA) SUPPORT SERVICES FOR THE FDA'S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) THROUGH A DIRECT 8(A) AWARD OF A SINGLE, LABOR-HOUR (LDepartment of Health and Human ServicesAug 26, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,155,825USAspending

FY2024 awards to ANEON BRILLIENT, LLC, largest first (obligated to date)

  • 75F40124C00111DIRECT 8(A) AWARD OF A 12-MONTH BASE, LABOR HOUR TYPE CONTRACT TO ANEON BRILLIENT FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) FOR PROFESSIONAL SERVICES SUPPORT.
    Signed
    Aug 21, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $3,266,336
  • 75F40124C00085DIRECT 8(A) AWARD OF A 3-YEAR, LABOR-HOUR (LH) TYPE CONTRACT FOR COMMUNICATION, ADMINISTRATIVE & INFORMATION DISCLOSURE SUPPORT SERVICES FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), OFFICE OF
    Signed
    Aug 26, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $2,366,901
  • 75F40124C00090DIRECT 8(A) AWARD OF A 12-MONTH BASE AND 9-MONTH OPTION, LABOR HOUR TYPE CONTRACT TO ANEON BRILLIENT FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) FOR PROFESSIONAL SERVICES.
    Signed
    Aug 2, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $2,214,286
  • 75F40124C00068DIRECT 8(A) AWARD, STAND-ALONE, LABOR-HOUR (LH) TYPE CONTRACT FOR FOOD AND DRUG ADMINISTRATION ONCOLOGY CENTER FOR EXCELLENCE ONCOLOGY CENTER OF EXCELLENCE PROFESSIONAL SERVICES.
    Signed
    Jun 24, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,866,747
  • 75F40124C00076DIRECT 8(A) AWARD OF A 3-YEAR, LABOR-HOUR (LH) TYPE CONTRACT FOR PROGRAM SUPPORT SERVICES FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), OFFICE OF POLICY, LEGISLATION AND INTERNATIONAL AFFAIRS (OPLIA)
    Signed
    Aug 27, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,619,126
  • 75F40124C00115DIRECT 8(A) AWARD OF 4-YEAR, LABOR HOUR TYPE CONTRACT TO ANEON BRILLIENT TO PROVIDE MEDICAL AND SCIENTIFIC WRITING & EDITING FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)
    Signed
    Aug 21, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $1,576,247
  • 75F40124C00109THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HEREBY INTENDS TO PROCURE THE FREEDOM OF INFORMATION ACT (FOIA) SUPPORT SERVICES FOR THE FDA'S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) THROUGH A DIRECT 8(A) AWARD OF A SINGLE, LABOR-HOUR (L
    Signed
    Aug 26, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,155,825
7 awards. Source: USAspending.gov award records.
Recipient records grouped under this company (1)

USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to ANEON BRILLIENT, LLC; the stock link below is made per recipient.

  • ANEON BRILLIENT, LLC10 awards · 10 non-competed, $20.8M obligated to date

Stock ticker

Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.

No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant.

Members of Congress who reported trading this stock

No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant. Without a confirmed ticker, no trades are matched to this company.

Looking for agency-level shares? See non-competed share by agency.